NIH-funded research R01 grant

Cholesterol's effects on insulin-producing pancreatic cells

Official title: Effects of Cholesterol in Pancreatic Islets

Funded at Seattle Inst for Biomedical/clinical Res · NIH-11319817 · Data updated 2026-11-12

This work looks at how cholesterol changes linked to statin use can harm insulin-making pancreatic beta cells in adults.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSeattle Inst for Biomedical/clinical Res
NIH-funded
Lab location1 site (Seattle, United States)
Project startApril 1, 2023
Project endMarch 31, 2027
Funding year2026
Award (this year)$430,797
NIH project number5R01DK134502-04
Project IDNIH-11319817 on NIH RePORTER

Who could benefit from this research

Could help

Adults taking statin medications or adults at risk for type 2 diabetes would be most relevant to this research.

Less likely to help

Children, people with type 1 diabetes, or patients not taking statins are unlikely to directly benefit from this project.

What this research studies

Researchers will study pancreatic islet beta cells (the cells that make insulin) in the lab to see how statins cause cholesterol to build up inside cell mitochondria. They will focus on cholesterol transport proteins called StAR and STARD3 that appear increased after statin exposure and test how changing these proteins affects mitochondrial cholesterol, insulin release, and cell survival. Experiments use isolated islets and molecular tools to raise or lower these transport proteins while measuring cell function, cholesterol levels, and markers of cell death. The goal is to understand the chain of events so we can point to ways to protect beta cells in people taking statins.

Why it matters

Potential benefit: If successful, the work could reveal targets to prevent statin-related loss of insulin production and lower the risk of new-onset type 2 diabetes.

How similar studies have gone: Previous clinical and laboratory studies show statins can raise diabetes risk and impair beta-cell function, but linking mitochondrial cholesterol accumulation and transport proteins like StAR/STARD3 is a newer, less-tested idea.

Where this research is happening

  • Seattle Inst for Biomedical/clinical Res
    Seattle, United States
    Active

Researchers

  • Principal investigator: Zraika, Sakeneh — Seattle Inst for Biomedical/clinical Res
  • Study coordinator: Zraika, Sakeneh

Related research

Other NIH-funded projects on the same topics.

  • Military Service–Linked ALS Risk in U.S. Veterans

    This NIH grant investigates why U.S. veterans get ALS more often, by studying military exposures and health records to identify potential risk factors.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11565245

  • Targeting MSUT2 with small molecules to slow tau-related dementia

    Aims to test whether small molecules that block MSUT2’s interaction with RNA can slow or reverse tau-related brain damage in people affected by Alzheimer’s disease and related dementias.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11463459

  • SPOP's role in tau-related brain disease

    Researchers are studying how a protein called SPOP affects tau-related brain damage in Alzheimer's-type conditions, using a small worm model to mirror human disease and look for ways to protect brain cells.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11463455

  • Comparing medicines and weight-loss surgery for liver disease linked to metabolic problems

    This program looks at how two drugs and bariatric surgery work for adults with metabolic dysfunction–associated steatohepatitis (MASH) and liver fibrosis.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11448529

  • Dementia with Lewy Bodies Consortium

    A national research effort to better understand and diagnose Lewy body dementia by studying biomarkers and patient data over time.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11412709

  • Post-TBI Sleep Problems and Alzheimer’s/CTE Brain Changes

    This grant studies whether sleep disruption after a traumatic brain injury increases the risk of Alzheimer’s disease and related brain changes later on, with a focus on people who’ve had mTBI.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11397349

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.